ANTIMICROBIAL THERAPY;
ARTICLE;
BRUCELLOSIS;
DRUG CHOICE;
DRUG CONTRAINDICATION;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
HUMAN;
LONG TERM CARE;
MONOTHERAPY;
PREGNANCY;
PRIORITY JOURNAL;
RELAPSE;
TREATMENT DURATION;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
Hospital-based surveillance for acute febrile illness in Egypt: a focus on community-acquired bloodstream infections
Afifi S., Earhart K., Azab M.A., Youssef F.G., EL Sakka H., Wasfy M., et al. Hospital-based surveillance for acute febrile illness in Egypt: a focus on community-acquired bloodstream infections. Am J Trop Med Hyg 2005, 73:392-399.
Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis
Smits H.L., Abdoel T.H., Solera J., Clavijo E., Diaz R. Immunochromatographic Brucella-specific immunoglobulin M and G lateral flow assays for rapid serodiagnosis of human brucellosis. Clin Diagn Lab Immunol 2003, 10:1141-1146.
A multicenter therapeutic study of 1100 children with brucellosis
Lubani M.M., Dubin K.I., Sharda D.C., Ndhar D.S., Araj G.F., Hafez H.A., et al. A multicenter therapeutic study of 1100 children with brucellosis. Pediatr Infect Dis J 1989, 8:75-78.
Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis
Montejo J.M., Alberola I., Gonzalez-Zarate P., Alvarez A., Alonso J., Canovas A., et al. Open, randomized therapeutic trial of six antimicrobial regimens in the treatment of human brucellosis. Clin Infect Dis 1993, 16:671-676.
FAO/WHO. FAO/WHO Expert Committee on Brucellosis. Sixth report. Geneva: World Health Organization
FAO/WHO. FAO/WHO Expert Committee on Brucellosis. Sixth report. Geneva: World Health Organization; 1986.
(1986)
9
0031606549
Multivariate model for predicting relapse in human brucellosis
Solera J., Martinez-Alfaro E., Espinosa A., Castillejos M.L., Geijo P., Rodriguez-Zapata M. Multivariate model for predicting relapse in human brucellosis. J Infect 1998, 36:85-92.